Group 1 - Alzamend Neuro, Inc. (ALZN) is a notable stock in the Medical sector, which consists of 1010 individual stocks and ranks 2 in the Zacks Sector Rank [2] - The Zacks Rank system indicates that Alzamend Neuro, Inc. has a Zacks Rank of 2 (Buy), with a significant increase of 88.2% in the consensus estimate for its full-year earnings over the past three months, reflecting improved analyst sentiment [3] - Year-to-date, Alzamend Neuro, Inc. has returned 1.7%, outperforming the Medical sector's average return of -3.3% [4] Group 2 - Alzamend Neuro, Inc. is part of the Medical - Biomedical and Genetics industry, which includes 512 companies and currently ranks 74 in the Zacks Industry Rank; this industry has an average loss of 11.9% year-to-date, indicating that ALZN is performing better [6] - Another stock in the Medical sector, Beam Therapeutics Inc. (BEAM), has also shown strong performance with a year-to-date return of 6.4% and a Zacks Rank of 2 (Buy) [4][5] - Investors in the Medical sector should monitor both Alzamend Neuro, Inc. and Beam Therapeutics Inc. for their continued solid performance [7]
Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?